Interleukin-2 and cancer--physiological and pharmacological uses.
Huland
E
E
D000818:Animals; D004261:DNA Replication / Q000187:drug effects; D004341:Drug Evaluation; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007167:Immunotherapy; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D009374:Neoplasms, Experimental / Q000188:drug therapy; D015375:Receptors, Interleukin-2 / Q000187:drug effects / Q000502:physiology; D013601:T-Lymphocytes / Q000187:drug effects; D016896:Treatment Outcome
D007155:Immunologic Factors; D007376:Interleukin-2; D015375:Receptors, Interleukin-2